Cucinotta, L.; Palermo, N.; Ardizzone, A.; Capra, A.P.; Campolo, M.; Esposito, E.; Casili, G.; Lanza, M.
The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury. Antioxidants 2025, 14, 442.
https://doi.org/10.3390/antiox14040442
AMA Style
Cucinotta L, Palermo N, Ardizzone A, Capra AP, Campolo M, Esposito E, Casili G, Lanza M.
The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury. Antioxidants. 2025; 14(4):442.
https://doi.org/10.3390/antiox14040442
Chicago/Turabian Style
Cucinotta, Laura, Nicoletta Palermo, Alessio Ardizzone, Anna Paola Capra, Michela Campolo, Emanuela Esposito, Giovanna Casili, and Marika Lanza.
2025. "The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury" Antioxidants 14, no. 4: 442.
https://doi.org/10.3390/antiox14040442
APA Style
Cucinotta, L., Palermo, N., Ardizzone, A., Capra, A. P., Campolo, M., Esposito, E., Casili, G., & Lanza, M.
(2025). The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury. Antioxidants, 14(4), 442.
https://doi.org/10.3390/antiox14040442
